Akthelia’s intellectual property portfolio underpins a unique technology in a field where there is growing need for new therapeutic solutions. Licensing partnerships and strategic alliances can help achieve significant impact through collaborative drug discovery and development.
Further information about Akthelia Pharmaceuticals and its product development programmes regarding the advancement of novel treatments for infectious diseases can be obtained by contacting the company at its
Head Office below:
101 Reykjavik, ICELAND
Phone: +354 510 1800